Literature DB >> 19019091

Differential effects of tumour necrosis factor-alpha and interleukin-12 on isopentenyl pyrophosphate-stimulated interferon-gamma production by cord blood Vgamma9 T cells.

Eduardo Jose Campos Alberto1, Naoki Shimojo, Masahiko Aoyagi, Yoichi Kohno.   

Abstract

Lower numbers of Vgamma9Vdelta2 T cells in cord blood (CB) than in adult peripheral blood (PB), as well as their impaired ability to produce interferon-gamma (IFN-gamma) in response to stimulation, are associated with functional deficiency in the immune system in newborns. In this study, we stimulated CB Vgamma9 T cells with their T-cell receptor-specific ligand, isopentenyl pyrophosphate (IPP), plus exogenous costimulatory cytokines such as interleukin-2 (IL-2), IL-12 and tumour necrosis factor-alpha (TNF-alpha), which are known to play important roles in the activation of PB gammadelta T cells. Our data show that CB Vgamma9 T cells are able to produce IFN-gamma at levels comparable to PB Vgamma9 T cells by the addition of TNF-alpha in the presence of IPP and IL-2; however, under the same culture conditions, IL-12 does not efficiently activate CB Vgamma9 T cells to produce IFN-gamma. The frequency of TNF-alpha receptor II-positive Vgamma9T cells and the expression levels of TNF-alpha receptor II are similar in CB and PB; in contrast, the frequency of IL-12 receptor betaI (IL-12RbetaI) -positive Vgamma9T cells and expression levels of IL-12RbetaI are significantly lower in CB than PB. TNF-alpha but not IL-12 increases the expression of IL-2Rbeta on CB Vgamma9 T cells. These results provide new insights into the role of TNF-alpha in the activation of CB Vgamma9 T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019091      PMCID: PMC2691782          DOI: 10.1111/j.1365-2567.2008.02983.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.

Authors:  M Kroca; A Tärnvik; A Sjöstedt
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

3.  Cord blood leucocyte expression of functionally significant molecules involved in the regulation of cellular immunity.

Authors:  S Hodge; G Hodge; R Flower; P Han
Journal:  Scand J Immunol       Date:  2001-01       Impact factor: 3.487

4.  Ontogeny of gamma delta T cells in humans.

Authors:  Stephen C De Rosa; James P Andrus; Stephen P Perfetto; John J Mantovani; Leonard A Herzenberg; Leonore A Herzenberg; Mario Roederer
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

5.  Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.

Authors:  S Goriely; B Vincart; P Stordeur; J Vekemans; F Willems; M Goldman; D De Wit
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 6.  Biological functions of tumor necrosis factor cytokines and their receptors.

Authors:  Klaus Pfeffer
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

7.  Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

Authors:  John M Sanders; Subhash Ghosh; Julian M W Chan; Gary Meints; Hong Wang; Amy M Raker; Yongcheng Song; Alison Colantino; Agnieszka Burzynska; Pawel Kafarski; Craig T Morita; Eric Oldfield
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

8.  Vdelta2 T-lymphocyte responses in cord blood samples from Italy and Côte d'Ivoire.

Authors:  Cristiana Cairo; Giorgio Mancino; Giulia Cappelli; C David Pauza; Elena Galli; Ercole Brunetti; Vittorio Colizzi
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

9.  Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines.

Authors:  B Cipriani; G Borsellino; F Poccia; R Placido; D Tramonti; S Bach; L Battistini; C F Brosnan
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  4 in total

1.  Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates.

Authors:  Jinrong Li; Hong Li; Huawei Mao; Meixing Yu; Fan Yang; Ting Feng; Yingying Fan; Qiao Lu; Chongyang Shen; Zhongwei Yin; Meng Mao; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

2.  Vγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates.

Authors:  Jinrong Li; Hong Li; Huawei Mao; Meixing Yu; Ting Feng; Fan Yang; Yingying Fan; Qiao Lu; Chongyang Shen; Zhongwei Yin; Wenwei Tu; Meng Mao
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

3.  Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants.

Authors:  Huaqiong Huang; Jordy Saravia; Dahui You; Aaron J Shaw; Stephania A Cormier
Journal:  Immunol Cell Biol       Date:  2014-09-30       Impact factor: 5.126

4.  Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility.

Authors:  Sofia Berglund; Ahmed Gaballa; Piamsiri Sawaisorn; Berit Sundberg; Michael Uhlin
Journal:  Stem Cells Int       Date:  2018-03-07       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.